Increased expression of eVim and its post-translationally modified (PTM) form, citrullinated vimentin (CitVim), has been observed in various acute inflammatory conditions such as sepsis and chronic conditions like pulmonary fibrosis or rheumatoid arthritis (RA) [14–16]. Here, VIM is linked to rheumatoid arthritis.